Status:
COMPLETED
Immune Modulation by Enhanced vs Standard Prehabilitation Program Before Major Surgery
Lead Sponsor:
Stanford University
Conditions:
Surgery
Immune System and Related Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Over 30 million surgeries are performed annually in the US. Up to 30% of surgical patients experience delayed surgical recovery, marked by prolonged post-surgical pain, opioid consumption, and functio...
Detailed Description
The study design is a prospective monocenter single-blinded randomized controlled trial in patients undergoing elective major abdominal surgery. * Patients will be recruited during the surgical consu...
Eligibility Criteria
Inclusion
- Adult patients (≥ 18 years)
- Competent to provide informed consent
- Undergoing major elective surgery under general anesthesia in ≥14 days from enrollment (abdominal, thoracic, plastic and neurosurgeries).
- Fluent in English
Exclusion
- Premorbid conditions or orthopedic impairments with contraindications to exercise
- Cognitive disabilities defined as evolutive neurological or neurodegenerative disease
- ASA score 4 or higher or patient under palliative care
- Illiteracy (inability to read the English language).
- Expected length of stay at hospital \< 48 hours
- Patient under tutorship or curatorship
- Pregnant or breast-feeding woman
- Absence of informed consent or request to not participate to the study
Key Trial Info
Start Date :
October 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 21 2024
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT04498208
Start Date
October 7 2020
End Date
April 21 2024
Last Update
April 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305